TRASTUZUMAB BULTECAN
UNII QW54UB3V97

Substance Identification & Data

This profile provides standardized clinical and technical data for Trastuzumab Bultecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QW54UB3V97.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033451-22-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
QW54UB3V97
CAS Registry Number
3033451-22-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TRASTUZUMAB BULTECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224798
National Cancer Institute reference terminology for clinical and research data.
INN ID
13660
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trastuzumab Bultecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TRASTUZUMAB BULTECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB HER2 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB HER2 .KAPPA.-CHAIN, DIMER, OCTAKIS(THIOETHER) WITH N5-(1-DEOXY-D-GLUCITOL-1-YL)-N2-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-GLUTAMINYL-L-VALYL-N-((4-((4S)-4-ETHYL-8-FLUORO-3,4,12,14-TETRAHYDRO-9-METHYL-4-HYDROXY-3,14-DIOXO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-10-YL)BUTOXY)METHYL)-L-ALANINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EPIDERMAL GROWTH FACTOR RECEPTOR 2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF EIGHT CYSTEINYL RESIDUES TO BULTECAN GROUPS, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (TRASTUZUMAB BULTECAN)
TRASTUZUMAB BULTECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus